ReleaseWire

ENANDE GmbH announced today that the Kindle version of the book, To Fuse or Not to Fuse: How Artificial Disc Replacement, Hybrid Fusion, and Fusion Alternatives are Changing the World of Spinal Fusion became an Amazon #1 Bestseller on March 9th 2017, having reached #1 in four categories in the United States, three categories in Canada, and three categories in Germany. The book later became featured as the #1 bestseller in Australia too, in the categories of orthopedic surgery and others. Amazon also featured the book as the #1 Hot New Release in multiple categories. The book is available now on Amazon.

Xtremely rare do investors see companies and insiders buying back shares on an OTC listed company, but EKNL looks to be doing just that making share inventory scarcer by the day and super thin.

As the international battle with coronavirus continues, scientists in Europe have been testing the efficacy of mixing the AstraZeneca vaccine with the Pfizer vaccine.

Throughout the international health crisis, the worldwide market for pharmaceutical contract manufacturing, which was anticipated to be worth US$ 100 billion in 2020, is expected to grow to US$130.2 billion by 2026.

In June, Germany's industrial production unexpectedly decreased 1.3% from the previous month, as supply chain disruptions continued to pose problems for manufacturers across the country.

Flooding and torrential downpours have wreaked havoc on regions of western Europe with Germany and Belgium seeing some of the worst floods, causing pressure to mount on the already depleted supply chain by reducing the movement of cargo in and out of the region. This year's shipping has already been severely disrupted, with increased expenditures as areas of the world recovered from the coronavirus pandemic which resulted in a shortage of containers, causing catastrophic delays.

New research has indicated that the most crucial technology trend within the German industry is the noteworthy transition from hardware to services. In the digital age, Germany's technology sector has proven to be of vital importance. Not only does the industry produce sales revenues that exceed €230 billion annually, representing 7% of German GDP, but it is also a key enabler that has a significant influence on other industries.

Germany's software development industry is booming. Within Europe, it represents the largest software market covering around 25% of the total European market, ahead of the United Kingdom and France.

Stocks and shares of airlines have been unstable since the start of the coronavirus pandemic, with international travel having been subjected to some of the strictest restrictions across Europe. Earlier this month, Germany lifted some of the tough restrictions placed on visitors from countries such as the UK and Portugal, which resulted in a positive uptick but then quickly nosedived. Airlines such as Lufthansa, Ryanair, and the International Airlines Group all saw gains before the stocks across Europe fell with the pan-European Stoxx 600, London, Paris, and Frankfurt all seeing decreases.

A recent survey of institutional investors and wealth managers from the United States, United Kingdom, France, Germany, and the United Arab Emirates, who collectively manage $275 billion in assets revealed that security concerns about digital assets and custodial services are a 'significant hurdle' preventing many from investing in crypto assets for the first time.

According to the latest Biotech-Report for Germany conducted by Boston Consulting Group for VFA Bio, Germany remains the second largest manufacturer of active biopharmaceutical substances licenced by the European Union, with biopharmaceutical sales accounting for 30.8% of the overall medicines market. Based on the current study, biopharmaceutical sales (in the pharma and hospital sector) reached €14.6 billion in 2020, up 14% from the previous year.

Over the last century pharmaceutical researchers have been able to produce increasingly effective medications based on particular active components. Thanks to professionals in the research and development roles, we as a global society have been able to overcome numerous epidemics in very short periods of time through innovative and ground-breaking treatments.

In the current climate of working from home and online meetings, video conference tools like Zoom have safeguarded businesses' abilities to continue working effectively during the coronavirus pandemic. However, when conducting international business, language barriers can continue to impede effective trade.

To take advantage of the digital transition that is underway in every aspect of modern life, procurement professionals must adapt and adjust to the new technologies and possibilities that can yield higher levels of productivity. The majority of older procurement procedures were designed around the aims of procurement, rather than processes that could have been helpful for those within the business. Procurement teams are now able to put the needs of the business at the core of every decision as a direct result of digitalisation. Platforms that concentrate on what users want can help improve compliance and play a greater role in generating development across an organisation.

Bavaria, Germany's southernmost state, is in discussions with Intel to establish a European chip factory to alleviate supply constraints that have hindered automobile manufacturing, according to ministers. The US-based manufacturer has been pursuing 8 billion euros in government subsidies to establish a semiconductor manufacturing facility in Europe. A scarcity of semiconductors is causing problems for Europe's car manufacturers and may jeopardise Germany's economic recovery in the wake of the COVID-19 pandemic.

In May, the German Bundestag approved new legislation with regards to autonomous driving cars and is just awaiting the signature of the Chancellor. This new regulation paves the way for businesses to begin turning a profit from autonomous driving services, which, in turn, would boost research and development into the technology.

The recent geopolitical developments, in regards to the pandemic, have appeared to create a fiasco in the commodities sector. From national lockdowns disrupting supply chains to monetary and fiscal stimulus fuelling inflation fears, many are debating whether we have entered a commodity supercycle where the supply and demand ratio becomes skewed.

During the first quarter of 2021, fund firms in Germany received net inflows of €59.9 billion. That is their greatest new business performance in six years, from the beginning of January to the end of March.

The development of more effective drug treatments to help those infected with COVID-19 is underway across Germany. Medicines of varying types, such as antiviral medicines, cardiovascular medicines, dampening immunomodulators, and medicines for lung function are being developed to help those suffering from the virus. According to the American organisation BIO, more than 600 different drugs are now being investigated to determine whether they can aid in combatting COVID-19 in any way. Most have previously been authorised or are in the process of being authorised for another illness. Repurposing drugs tends to be a faster way to yield development, rather than researching medications from scratch.

Over the last few decades, technological developments have provided new challenges and opportunities for the supply chain and logistics industry. This doesn't appear to be slowing down as we move into the age of 5G. Although the long-term capabilities of 5G won't be fully comprehended for a few more years, this new technology offers improved communication abilities through faster data speeds with less latency. Thanks to the fast data speeds 5G provides, manufacturing, and other sectors such as procurement and logistics, will be able to perform very accurate processes.

For many years procurement's function and prominence have been growing and this trend was further accelerated during the coronavirus pandemic. Leaders exhibited their capacity to adapt to a variety of setbacks, keeping supply flowing and expenses in check. Innovative procurement executives foresee its potential for growth as the goals of companies change from attempting to limit the negative consequences of the pandemic to resuming economic expansion.

Josef Lieven and his software engineering team are set to release Germany's first online vaccination passport, with the ambitious goal of enabling Europeans to travel this summer. T-Systems and software developer SAP, the two companies that created Germany's contact-tracing app, have been assigned by the European Commission to create a digital certificate. The certificate will verify whether a person has been fully vaccinated against COVID-19, provided a negative test result, or possesses antibodies. The data is saved in a QR code which is authenticated by the EU, as well as its neighbours, Iceland, Norway, and Liechtenstein.

Opportunities for research, innovation, and corporate expansion must all be considered within a biotechnological strategy for growth. Public-private corporations have the potential to foster such growth with the establishment of centres of excellence. Prospects include technologies that integrate components of pharmaceutical research and molecular biology which will drive the industry forward. Discovering and supplying medications that comply with the biology and pathophysiology of each unique patient will be one of the most pressing challenges facing the biotechnology sector in the 21st century. The move from mass-produced medicine to bespoke medicine will have a significant impact on the future development and prescribing of medications.

New data protection technologies like responsible artificial intelligence can help innovative businesses compete in a highly competitive digital market. The numerous restrictions that have been implemented emphasise the necessity for businesses to protect the privacy of anybody whose personally identifiable information (PII) is stored in their systems. New data security approaches enable businesses to reap profits from sensitive data while also fostering trust by guaranteeing that customers' and employee's privacy is always protected. Organisations across the board must protect privacy consistently and competently regardless of where information sits or how data is accessed. This enables businesses to leverage sensitive data to power sophisticated analytics, machine learning, and artificial intelligence projects, despite the shift to the cloud.

Logistics is a central pillar of Germany's productivity, opening the way for added industrial value, product movement, and inter-organisation collaboration. The logistics industry in Germany is the third-largest contributor to the country's GDP, behind only foreign trade and the automobile industry. The logistics industry hires roughly three million people and generates €200 billion in annual revenue, accounting for an estimated 7% of the country's GDP. The logistics industry is growing at a much faster rate than the rest of the economy. In Germany, about €15 billion is spent on logistics annually.

Many carriers and regulators around the world have had their 5G plans disrupted by the COVD-19 pandemic, which has resulted in delayed or cancelled spectrum auctions and limits on towner construction. Despite this, there were more commercial 5G launces in 2020 than ever before.

R&D spend has been a priority in Germany over the past decade, making this one of the prime locations in Europe for R&D jobs. The most recent government data has revealed that spending on R&D in Germany is gradually getting closer to an initially ambitious target that was set - 3.5% of GDP. The data comes from the Federal Report for Research and Innovation and shows that Germany has made significant progress towards this R&D spending target. In fact, according to the figures spending has gone above 3% of GDP, which is an impressive achievement.